Latest News

A master’s student in Allergy at the University of Southampton is seeking volunteers aged 18 or over who have three or more confirmed food allergies from the UK’s top 14 major allergens. Alternatively, volunteers may be the parent of a

Whether you’re a first-time school parent or preparing to send your little one off to “big school”, choosing the right setting can feel both exciting and overwhelming. For families of children with allergies, there’s the added challenge of making sure the school not only understands

Last Wednesday (12 November), we were proud to host our second Business Symposium — an inspiring gathering of more than 140 professionals from the food industry and regulatory sectors. Held at The Edgbaston Park Hotel and Conference Centre, the day

Following some recent queries, we’ve put together a few tips to help you check whether your Adrenaline Auto-Injectors (AAIs) need replacing.  Adrenaline is the first-line treatment for serious allergic reactions (anaphylaxis). It is available on prescription in a pre-loaded injection

Anaphylaxis UK announces that Simon Williams has stepped down from his role as Chief Executive to pursue other opportunities.

The National Allergy Strategy Group (NASG) – an alliance between professional organisation BSACI and patient charities including Anaphylaxis UK, Allergy UK, and the Natasha Allergy Research Foundation — is calling on the allergy community to take part in the final

Anaphylaxis UK is delighted to announce a new partnership with the Out of School Alliance (OOSA) — a leading membership organisation supporting providers of wraparound care and holiday clubs across the UK. This collaboration will make it even easier for

Back in July, we welcomed the news that the UK medicines regulator (MHRA) had approved the country’s first needle-free adrenaline nasal spray, EURneffy® for people living with serious allergies. And in another positive step forward, EURneffy® is now available on prescription in the UK.

A new UK study led by Imperial College London, published in Archives of Disease in Childhood, finds that providing every school with spare adrenaline auto-injectors (AAIs) could improve emergency care for children and save the NHS at least £4.6 million a year.